Pharmaceutics (Oct 2021)

Green Metallic Nanoparticles for Cancer Therapy: Evaluation Models and Cancer Applications

  • Ernesto Tinajero-Díaz,
  • Daniela Salado-Leza,
  • Carmen Gonzalez,
  • Moisés Martínez Velázquez,
  • Zaira López,
  • Jorge Bravo-Madrigal,
  • Peter Knauth,
  • Flor Y. Flores-Hernández,
  • Sara Elisa Herrera-Rodríguez,
  • Rosa E. Navarro,
  • Alejandro Cabrera-Wrooman,
  • Edgar Krötzsch,
  • Zaira Y. García Carvajal,
  • Rodolfo Hernández-Gutiérrez

DOI
https://doi.org/10.3390/pharmaceutics13101719
Journal volume & issue
Vol. 13, no. 10
p. 1719

Abstract

Read online

Metal-based nanoparticles are widely used to deliver bioactive molecules and drugs to improve cancer therapy. Several research works have highlighted the synthesis of gold and silver nanoparticles by green chemistry, using biological entities to minimize the use of solvents and control their physicochemical and biological properties. Recent advances in evaluating the anticancer effect of green biogenic Au and Ag nanoparticles are mainly focused on the use of conventional 2D cell culture and in vivo murine models that allow determination of the half-maximal inhibitory concentration, a critical parameter to move forward clinical trials. However, the interaction between nanoparticles and the tumor microenvironment is not yet fully understood. Therefore, it is necessary to develop more human-like evaluation models or to improve the existing ones for a better understanding of the molecular bases of cancer. This review provides recent advances in biosynthesized Au and Ag nanoparticles for seven of the most common and relevant cancers and their biological assessment. In addition, it provides a general idea of the in silico, in vitro, ex vivo, and in vivo models used for the anticancer evaluation of green biogenic metal-based nanoparticles.

Keywords